Emily Heffernan, PE, US Director, New Process Technologies, at DPS, is a process subject matter expert specializing in biological process and facility design. Working in the life sciences for 20 years, she has gained expertise in designing facilities for monoclonal antibodies, vaccines, and novel therapies including cell and gene therapy production. She is recognized for her subject matter expertise in multi-modal facilities where different product types are produced in the same facility, due to her deep knowledge of complex facility layouts, GMP flows, and regulatory considerations. Emily holds a BScience in chemical engineering and BS in biochemistry, both from North Carolina State University. Emily is a frequent author and presenter and has spoken at industry leading events in the United States and Europe including ISPE, PDA, and Interphex. She has been an ISPE member since 2021.
